Key Market Indicators
Sales of digestive system disorder medicines in Estonia are predicted to reach $54.2 million by 2026. This is up from $48.1 million in 2021 – an average annual growth rate of 1.9%. Since 2004, the Estonian market has grown by an average of 4.8% a year. In 2021, Estonia was ranked number 26 in the world for such sales. Latvia was ahead with $48.1 million. Japan, South Korea and Canada placed second, third and fourth respectively.
